BBCNEWS Verified Live June 4, 2024 16:52:00
But we havent had that. weve had decades of failed trials in alzheimers. this is actually the second drug. the first that cleared amyloid, which reported last year, is called lecanemab. works in a very similar way. that is actually licensed in the us at a cost around $27,000 — £21,000. so that gives an idea of what it might cost if its introduced in the uk. both those drugs could be licensed in the uk next year, but health services here and around the world will have to see if they move now t...
Source: archive.org